Chromosome Microarray Analysis Differentiated Between Benign and Cancerous Fatty Tissue Tumors
PHILADELPHIA (June 18, 2021)–Researchers at Fox Chase Cancer Center are using a powerful single nucleotide polymorphism-based chromosome microarray (CMA) to differentiate between benign and cancerous lipomatous tumors.